Moderna (MRNA) beats estimates in Q1 2024, targets RSV vaccine launch in fall
Go back to Moderna (MRNA) beats estimates in Q1 2024, targets RSV vaccine launch in fall| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 59.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.35 | 52 Week High | $0.52 | |||
| Open | $59.35 | 52 Week Low | $0.08 | |||
| Day High | $59.35 | P/E | N/A | |||
| Day Low | $59.35 | EPS | $-3.80 | |||
| Volume | 48,130 | |||||
